Biotech’s Recovery Isn’t a ‘Head fake.’  These 3 Stocks Could Lead the Next Leg Up

Biotech's recovery isn't a 'head fake.'  These 3 stocks could lead the next leg up

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Biotech’s recovery isn’t a ‘head fake.’  These 3 stocks could lead the next leg up

The stock market’s attention has been focused almost exclusively on artificial intelligence, semiconductors and a handful of megacap technology companies. Investors looking for value may find one of the more compelling opportunities developing in a different corner of the market. Biotechnology has spent much of the past four years in a bear market. Rising interest rates, weaker venture funding and investor fatigue toward healthcare innovation pu…